Patents by Inventor Morten Bøhmer Strøm

Morten Bøhmer Strøm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Barbituric acid derivatives comprising cationic and lipophilic groups
    Patent number: 11072588
    Abstract: The present invention relates to bioactive cyclic compounds and their use as antimicrobial agents. In particular, the present invention relates to barbiturate mimics of Eusynstyelamides or small antimicrobial peptides. The compounds of the invention are represented by Formula (I).
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: July 27, 2021
    Assignee: Universitetet i Tromsø—Norges Arktiske Universitet
    Inventors: Morten Bøhmer Strøm, Annette Bayer, Stig Olov Magnus Engqvist, Marianne Hagensen Paulsen, Dominik Ausbacher
  • BARBITURIC ACID DERIVATIVES COMPRISING CATIONIC AND LIPOPHILIC GROUPS
    Publication number: 20200024240
    Abstract: The present invention relates to bioactive cyclic compounds and their use as antimicrobial agents. In particular, the present invention relates to barbiturate mimics of Eusynstyelamides or small antimicrobial peptides. The compounds of the invention are represented by Formula (I).
    Type: Application
    Filed: March 28, 2018
    Publication date: January 23, 2020
    Inventors: Morten Bøhmer Strøm, Annette Bayer, Stig Olov Magnus Engqvist, Marianne Hagensen Paulsen, Dominik Ausbacher
  • Method of treating tumors
    Patent number: 9115169
    Abstract: The invention provides a method of treating tumors by adminstering to a human or animal patient an effective amount of a molecule of 2 to 4 amino acids or equivalent subunits in length, which incorporates a bulky and lipophilic group comprising at least 13 non-hydrogen atoms and containing no more than 2 polar functional groups, in which the bulky and lipophilic group incorporates one or more closed rings of 5 or more non-hydrogen atoms, and in which the molecule further has at least two more cationic than anionic moieties.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: August 25, 2015
    Assignee: Lytix Biopharma AS
    Inventors: John Sigurd Svendsen, Bengt Erik Haug, Istvan Marko, Øystein Rekdal, Merete Linchausen Skar, Wenche Stensen, Morten Bøhmer Strøm
  • Antimicrobial Compounds and Formulations
    Publication number: 20120108520
    Abstract: The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilising microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics.
    Type: Application
    Filed: September 22, 2011
    Publication date: May 3, 2012
    Applicant: LYTIX BIOPHARMA AS
    Inventors: John Sigurd Svendsen, Bengt Erik Haug, Istvan Marko, Øystein Rekdal, Merete Linchausen Skar, Wenche Stensen, Morten Bøhmer Strøm
  • Antimicrobial compounds and formulations
    Patent number: 8048852
    Abstract: The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilizing microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: November 1, 2011
    Assignee: Lytix Biopharma AS
    Inventors: John Sigurd Svendsen, Bengt Erik Haug, Istvan Marko, Øystein Rekdal, Merete Linchausen Skar, Wenche Stensen, Morten Bøhmer Strøm
  • Antimicrobial compounds and formulations
    Patent number: 7232803
    Abstract: The invention relates to the use of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto at least two bulky and lipophilic groups and having at least one more cationic than anionic moiety, in the manufacture of a medicament for destabilizing microbial cell membranes and the use as a membrane acting antimicrobial agent of a molecule comprising a backbone of 2 to 35 non-hydrogen atoms in length, having covalently attached thereto a super bulky and lipophilic group comprising at least 9 non-hydrogen atoms and having at least two more cationic than anionic moieties and to methods of treatment involving such molecules, in particular peptides including peptide derivatives, and peptidomimetics.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: June 19, 2007
    Assignee: Lytix Biopharma AS
    Inventors: John Sigurd Svendsen, Bengt Erik Haug, Istvan Marko, Øystein Rekdal, Merete Linchausen Skar, Wenche Stensen, Morten Bøhmer Strøm